All Stories

  1. Prevention of Allodynia and Hyperalgesia by Cannabidiol in a Rat Model of Chemotherapy-Induced Peripheral Neuropathy

    Article • Journal of Visualized Experiments, June 2025, MyJove Corporation

    Michael Ippolito

  2. Effect of Fatty Acyl Composition for Lysophosphatidylinositol on Neuroinflammatory Responses in Primary Neuronal Cultures

    Article • January 2025, Springer Science + Business Media

    Michael Ippolito

  3. KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in Rats

    Article • Journal of Pharmacology and Experimental Therapeutics, November 2024, Elsevier

    Michael Ippolito

  4. Minor Cannabinoids as an Emerging Frontier for Pain Relief

    Article • Journal of Pharmacology and Experimental Therapeutics, November 2024, Elsevier

    Michael Ippolito

  5. Knockdown siRNA Targeting GPR55 Reveals Significant Differences Between the Anti-inflammatory Actions of KLS-13019 and Cannabidiol

    Article • Journal of Molecular Neuroscience, April 2024, Springer Science + Business Media

    Michael Ippolito

  6. Identification of a β-arrestin-biased negative allosteric modulator for the β 2 -adrenergic receptor

    Article • Proceedings of the National Academy of Sciences, July 2023, Proceedings of the National Academy of Sciences

    Michael Ippolito

  7. β2‐Adrenoceptor agonist profiling reveals biased signalling phenotypes for the β2‐adrenoceptor with possible implications for the treatment of asthma

    Article • Bone Marrow Transplantation, July 2022, Wiley

    Michael Ippolito

  8. Phenylalanine 193 in Extracellular Loop 2 of the β2-Adrenergic Receptor Coordinates β-Arrestin Interaction

    Article • Molecular Pharmacology, February 2022, Elsevier

    Michael Ippolito

  9. Biased agonism at β-adrenergic receptors

    Article • Cellular Signalling, April 2021, Elsevier

    Michael Ippolito

  10. Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines

    Article • The FASEB Journal, February 2018, Federation of American Societies For Experimental Biology (FASEB)

    Dr Deepak Deshpande, rey panettieri, Dr Bryan L Roth, Michael Ippolito